Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Health Net Oregon | Darolutamide (Nubeqa); CP.PHAR.435PayerPolicy · HEALTHNET_OR-CP-PHAR-435 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Apalutamide (Erleada); CP.PCH.45PayerPolicy · HEALTHNET_OR-CP-PCH-45 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Abiraterone (Yonsa, Zytiga); CP.PHAR.84PayerPolicy · HEALTHNET_OR-CP-PHAR-84 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Vismodegib (Erivedge); CP.PHAR.273PayerPolicy · HEALTHNET_OR-CP-PHAR-273 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Sonidegib (Odomzo); CP.PHAR.272PayerPolicy · HEALTHNET_OR-CP-PHAR-272 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Glasdegib (Daurismo); CP.PHAR.413PayerPolicy · HEALTHNET_OR-CP-PHAR-413 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Tisagenlecleucel (Kymriah); CP.PHAR.361PayerPolicy · HEALTHNET_OR-CP-PHAR-361 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Sipuleucel-T (Provenge); CP.PHAR.120PayerPolicy · HEALTHNET_OR-CP-PHAR-120 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Obecabtagene Autoleucel (Aucatzyl); CP.PHAR.675PayerPolicy · HEALTHNET_OR-CP-PHAR-675 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Lisocabtagene maraleucel (Breyanzi); CP.PHAR.483PayerPolicy · HEALTHNET_OR-CP-PHAR-483 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Lifileucel (Amtagvi); CP.PHAR.598PayerPolicy · HEALTHNET_OR-CP-PHAR-598 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Idecabtagene Vicleucel (Abecma); CP.PHAR.481PayerPolicy · HEALTHNET_OR-CP-PHAR-481 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Ciltacabtagene Autoleucel (Carvykti); CP.PHAR.533PayerPolicy · HEALTHNET_OR-CP-PHAR-533 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Brexucabtagene autoleucel (Tecartus); CP.PHAR.472PayerPolicy · HEALTHNET_OR-CP-PHAR-472 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Axicabtagene ciloleucel (Yescarta); CP.PHAR.362 (PDFPayerPolicy · HEALTHNET_OR-CP-PHAR-362 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Venetoclax (Venclexta); CP.PHAR.129PayerPolicy · HEALTHNET_OR-CP-PHAR-129 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Zenocutuzumab-zbco (Bizengri); CP.PHAR.713PayerPolicy · HEALTHNET_OR-CP-PHAR-713 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Zanubrutinib (Brukinsa); CP.PHAR.467PayerPolicy · HEALTHNET_OR-CP-PHAR-467 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Tremelimumab-actl (Imjudo); CP.PHAR.612PayerPolicy · HEALTHNET_OR-CP-PHAR-612 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Trastuzumab (Herceptin) and biosimilars; CP.PHAR.228PayerPolicy · HEALTHNET_OR-CP-PHAR-228 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Toripalimab-tpzi (Loqtorzi); CP.PHAR.668PayerPolicy · HEALTHNET_OR-CP-PHAR-668 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Tisotumab vedotin-tftv (Tivdak); CP.PHAR.561PayerPolicy · HEALTHNET_OR-CP-PHAR-561 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Tislelizumab-jsgr (Tevimbra); CP.PHAR.687PayerPolicy · HEALTHNET_OR-CP-PHAR-687 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Telisotuzumab Vedotin-tllv (Emrelis); CP.PHAR.733PayerPolicy · HEALTHNET_OR-CP-PHAR-733 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Teclistamab-cqyv (Tecvayli); CP.PHAR.611PayerPolicy · HEALTHNET_OR-CP-PHAR-611 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Tebentafusp-tebn (Kimmtrak); CP.PHAR.575PayerPolicy · HEALTHNET_OR-CP-PHAR-575 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Talquetamab-tgvs (Talvey); CP.PHAR.649PayerPolicy · HEALTHNET_OR-CP-PHAR-649 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Tarlatamab-dlle (Imdelltra); CP.PHAR.685PayerPolicy · HEALTHNET_OR-CP-PHAR-685 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Tafasitamab-cxix (Monjuvi); CP.PHAR.508PayerPolicy · HEALTHNET_OR-CP-PHAR-508 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Sacituzumab govitecan-hziy (Trodelvy); CP.PHAR.475PayerPolicy · HEALTHNET_OR-CP-PHAR-475 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Rituximab (Rituxan and biosimilars); CP.PHAR.260PayerPolicy · HEALTHNET_OR-HNOR-RITUXIMAB-RITUXAN-AND-BIOSIMILARS-CP-PHAR-260-2AB07480B9 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | retifanlimab-dlwr (Zynyz); CP.PHAR.629PayerPolicy · HEALTHNET_OR-CP-PHAR-629 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Polatuzumab vedotin-piiq (Polivy); CP.PHAR.433PayerPolicy · HEALTHNET_OR-CP-PHAR-433 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Pertuzumab (Perjeta), Pertuzumab-dpzb (Poherdy); CP.PHAR.227PayerPolicy · HEALTHNET_OR-CP-PHAR-227 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Penpulimab-kcqx; CP.PHAR.732PayerPolicy · HEALTHNET_OR-CP-PHAR-732 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Pembrolizumab, Pembrolizumab/Berahyaluronidase Alfa-pmph (Keytruda, Keytruda Qlex); CP.PHAR.322PayerPolicy · HEALTHNET_OR-CP-PHAR-322 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Panitumumab (Vectibix); CP.PHAR.321PayerPolicy · HEALTHNET_OR-CP-PHAR-321 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Ofatumumab (Arzerra, Kesimpta); CP.PHAR.306PayerPolicy · HEALTHNET_OR-CP-PHAR-306 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Nivolumab (Opdivo), Nivolumab/Hyaluronidase-nvhy (Opdivo Qvantig); CP.PHAR.121PayerPolicy · HEALTHNET_OR-CP-PHAR-121 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Naxitamab-gqgk (Danyelza); CP.PHAR.523PayerPolicy · HEALTHNET_OR-CP-PHAR-523 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Mosunetuzumab-axgb (Lunsumio); CP.PHAR.618PayerPolicy · HEALTHNET_OR-CP-PHAR-618 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Mogamulizumab-kpkc (Poteligeo); CP.PHAR.139PayerPolicy · HEALTHNET_OR-CP-PHAR-139 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Mirvetuximab soravtansine-gynx (Elahere); CP.PHAR.617PayerPolicy · HEALTHNET_OR-CP-PHAR-617 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Loncastuximab tesirine-Ipyl (Zynlonta); CP.PHAR.539PayerPolicy · HEALTHNET_OR-CP-PHAR-539 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Linvoseltamab-gcpt (Lynozyfic); CP.PHAR.743PayerPolicy · HEALTHNET_OR-CP-PHAR-743 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Isatuximab-irfc (Sarclisa); CP.PHAR.482PayerPolicy · HEALTHNET_OR-CP-PHAR-482 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Ipilimumab (Yervoy); CP.PHAR.319PayerPolicy · HEALTHNET_OR-CP-PHAR-319 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Inotuzumab Ozogamicin (Besponsa); CP.PHAR.359PayerPolicy · HEALTHNET_OR-CP-PHAR-359 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Glofitamab-gxbm (Columvi); CP.PHAR.636PayerPolicy · HEALTHNET_OR-CP-PHAR-636 | New policy |
|---|
| Aug 2, 2026 | Health Net Oregon | Gemtuzumab ozogamicin (Mylotarg); CP.PHAR.358PayerPolicy · HEALTHNET_OR-CP-PHAR-358 | New policy |
|---|